← Open Payments lookup

DAVID WICHMAN: Open Payments

NPI 1760695290 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$144,637 in 157 payments from 12 companies in 2025. Trend: 2023 $165,335 · 2024 $72,762 · 2025 $144,637

Speaker / faculty: $105,750Honoraria: $25,575Travel & lodging: $7,358Food & beverage: $5,954
CompanyPaymentsAmount
ABBVIE INC.110$113,466
Axsome Therapeutics, Inc.26$27,566
Brainsway USA INC1$3,120
Janssen Pharmaceuticals, Inc2$104
Alkermes, Inc.4$94
Otsuka America Pharmaceutical, Inc.3$75
Vanda Pharmaceuticals Inc.3$67
Neurocrine BioSciences, Inc.2$39
Supernus Pharmaceuticals, Inc.2$32
E.R. Squibb & Sons, L.L.C.2$31

Products named: VRAYLAR, Auvelity, Deep TMS System, SPRAVATO, ARISTADA, REXULTI, FANAPT, INGREZZA.

Industry payments across KS — which companies pay providers there.